The little-known pharmaceutical company, Emergent BioSolutions, was a key to Johnson & Johnson’s plan to deliver 100 million doses of its vaccine to the U.S. by the end of May.
Company at heart of J&J vaccine woes has series of citations
Credit: FOX 4 Now Florida
Duration: 00:39s
0 shares
2 views